LTS Lohmann Therapie Systeme AG

LTS cares for patients, partners, employees and communities, creates innovative drug delivery solutions, and delivers high-quality products worldwide. As a global CDMO, the company provides end-to-end development and manufacturing for pharma and biotech companies, with technologies including transdermal patches, oral thin films, nasal and sterile drug delivery products, wearable devices and microneedle patches, supporting more than 40 commercial products and more than 50 active programs advancing small molecules, biologics and vaccines.